Extra glutamine increases mortality in critically ill adultsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2527 (Published 24 April 2013) Cite this as: BMJ 2013;346:f2527
Early glutamine supplementation looked harmful to critically ill adults in a large trial that tested the supplements in intensive care units in Canada, the US, and Europe. Participants with multiorgan failure treated with glutamine had higher mortality than placebo …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial